Pyrinide 750 Tablet contains Pyrazinamide 750 mg, a first-line anti-tubercular medicine used in combination therapy to treat active tuberculosis. It works by inhibiting the synthesis of mycobacterial cell wall fatty acids, helping to stop bacterial replication.
This higher-dose formulation is commonly prescribed during the intensive phase of TB therapy, usually alongside Isoniazid, Rifampicin, and Ethambutol, ensuring effective bacterial clearance and improved treatment outcomes.
Belonging to the anti-infective and pulmonology segment, Pyrinide 750 Tablet is in consistent demand among hospitals, TB clinics, and government healthcare programs. Its essential role in standard TB regimens guarantees recurring market need.
For PCD pharma franchise partners, third-party manufacturers, and exporters, Pyrinide 750 Tablet provides a profitable B2B opportunity. Its high demand in TB treatment programs makes it a stable and rewarding product for pharma businesses across India.